The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Hosted on MSN1mon
Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drugTheir discovery may chart a path to a small-molecule drug that could be made available to all patients with sickle cell disease, as well as those with beta thalassemia. In sickle cell disease ...
Considering taking supplements to treat beta thalassemia? Below is a list of common natural remedies used to treat or reduce the symptoms of beta thalassemia. Follow the links to read common uses ...
3mon
Zacks.com on MSNEDIT Inks Collaboration Deal to Develop Novel Gene Editing TherapiesVRTX obtained a non-exclusive license to utilize Editas’ Cas9 gene editing technology for ex vivo gene editing medicines ...
Beta-thalassemia is a rare blood disorder caused by a genetic defect in hemoglobin. Several manufacturers are developing novel treatments for the disease, including Vertex, which has partnered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results